APA (7th ed.) Citation

Hu, Y., Eynikel, D., Boulet, P., & Krikorian, G. (2020, December). Supplementary protection certificates and their impact on access to medicines in Europe: Case studies of sofosbuvir, trastuzumab and imatinib. Journal of Pharmaceutical Policy and Practice.

Chicago Style (17th ed.) Citation

Hu, Yuanqiong, Dimitri Eynikel, Pascale Boulet, and Gaelle Krikorian. "Supplementary Protection Certificates and Their Impact on Access to Medicines in Europe: Case Studies of Sofosbuvir, Trastuzumab and Imatinib." Journal of Pharmaceutical Policy and Practice Dec. 2020.

MLA (9th ed.) Citation

Hu, Yuanqiong, et al. "Supplementary Protection Certificates and Their Impact on Access to Medicines in Europe: Case Studies of Sofosbuvir, Trastuzumab and Imatinib." Journal of Pharmaceutical Policy and Practice, Dec. 2020.